One facility, four disciplines of pharmaceutical manufacturing — a large-scale, purpose-built base spanning oral solids, oral liquids, topical formulations, and injectables, engineered to deliver breadth without compromising precision in any single format.
Located at Sector-8A, IIE SIDCUL, Ranipur, Haridwar, Uttarakhand — within India's pharmaceutical manufacturing corridor.
Few facilities cover this much manufacturing ground under one roof. Dedicated production areas separate solid dose, dermatology and liquid, and injectable operations — each run with its own specialized process discipline, while sharing a common backbone of quality and regulatory rigor.
This structure lets complex, multi-format product portfolios move through a single, tightly coordinated site — from a tablet to a topical cream to a sterile ampoule — without diluting the precision any one format demands.
Tablets, capsules, powders and dry syrups, produced across a wide-ranging solid dose portfolio.
Creams, ointments, syrups and suspensions, backed by an in-house research and development capability.
Ampoules, vials and blow-fill-seal formats, built for accuracy, integrity and speed of onset in injectable therapy.
Dry powder and large-volume parenterals, supporting acute and critical care needs.
Depth in every format is what sets this facility apart — solid, liquid, topical, and sterile production each engineered as a specialization in its own right.
A wide-ranging solid dose portfolio, including complex tablet architectures built for controlled and combination release.
A dedicated line for skin-applied and liquid formats, backed by an in-house research and development capability.
Sterile small-volume manufacturing built for accuracy, integrity, and speed of onset in injectable therapy.
Dedicated capacity for large-volume and dry-powder injectable production, supporting acute and critical care needs.
Format breadth translates into therapeutic breadth, with production supporting some of the most widely prescribed treatment categories.
Solid and liquid formulations addressing common infections.
Oral and topical formats supporting everyday pain management.
Syrups and suspensions formulated for respiratory relief.
Creams, lotions, and serums for a range of skin conditions.
Formulations supporting digestive and gastrointestinal wellbeing.
Injectable formats supporting fast-acting, hospital-grade therapy.
Reach spans many more therapeutic categories, supported by a manufacturing base built to move across formats without friction.
Running four manufacturing disciplines at scale, side by side, calls for engineering and process discipline most sites never need to develop.
Capability across bilayer, tablet-in-tablet, and tablet-in-capsule builds, engineered for controlled and combination release.
A dedicated development capability embedded alongside dermatology and liquid production, accelerating formulation-to-scale timelines.
Advanced aseptic technologies spanning ampoules, vials, dry powder, and blow-fill-seal injectable formats.
Physically separated manufacturing disciplines that let solid, liquid, topical, and sterile production scale independently.
Management systems governing quality, environment, and workplace safety operate consistently across every manufacturing discipline on site, regardless of dosage form — the shared backbone that lets solid, liquid, topical, and sterile production run to one consistent standard, batch after batch.
Quality Management Systems
Environmental Management
Occupational Health & Safety
Energy Management
Approvals from national health and drug authorities reflect sustained compliance and readiness to serve markets beyond India.
Food Safety and Drug Administration.
Ministry of Public Health and Population.
Regulatory presence continues to expand across many more markets, extending the reach of this multi-format manufacturing base.
Sited within the Sector-8A Integrated Industrial Estate at SIDCUL, Haridwar — a pharmaceutical manufacturing hub in Uttarakhand — the facility spans multiple dedicated production areas across a large, multi-plot campus. This scale allows solid dose, dermatology and liquid, and injectable operations to expand independently, each supported by infrastructure suited to its own manufacturing discipline.
A wide manufacturing footprint within the SIDCUL industrial estate, Haridwar.
Independent areas for solid dose, dermatology and liquids, and sterile injectables.
Formulation development integrated alongside dermatology and liquid manufacturing.
Infrastructure and systems aligned to the expectations of international regulatory authorities.
Plot No. 26A, 27-30, Sector-8A, IIE, SIDCUL, Ranipur, Haridwar-249403, Uttarakhand, India
Pure & Cure Healthcare Pvt. Ltd.
Oral Solid, Liquid, Topical & Injectable Manufacturing
Plant-VII manufactures across four disciplines: Solid Dose (tablets, capsules, powders, dry syrups), Dermatology & Liquids (creams, ointments, syrups, suspensions), Sterile Small-Volume (ampoules, vials, blow-fill-seal), and Sterile Large-Volume (dry powder & large-volume parenterals).
Plant-VII is located at Plot No. 26A, 27-30, Sector-8A, IIE, SIDCUL, Ranipur, Haridwar-249403, Uttarakhand, India — operated by Pure & Cure Healthcare Pvt. Ltd.
Yes. Solid dose, dermatology and liquids, and sterile injectable operations run in physically separated, discipline-segregated production areas, each supported by infrastructure suited to its own manufacturing process — while sharing one common quality and regulatory backbone.
Plant-VII holds ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 50001:2018 certifications, and is recognized by the Food Safety and Drug Administration, Uttarakhand, and Yemen's Ministry of Public Health and Population, among other authorities.
Yes. Plant-VII supports third-party and contract manufacturing programs across its solid dose, dermatology & liquid, and sterile injectable lines. Reach out via the form below to discuss your project requirements.
From solid dose to sterile injectables, this facility brings together precision, compliance, and scale across every format it manufactures. Therapeutic reach and regulatory presence continue to expand across many more categories and geographies.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.